retatrutide daily or weekly is one of the most exciting medications currently being studied for obesity and metabolic disease-but there's one important thing to understand: It is NOT approved yet. I get asked almost daily, “ Retatrutide Dosing: Weekly Injections, Clinical

Alzheimers disease and the basal forebrain cholinergic system

Longitudinal studies are warranted to investigate the association between peripheral redox status and brain maturation throughout the adolescent transition

Decreased urination or dark urine : Oliguria or concentrated urine may signal dehydration, particularly if accompanied by persistent nausea, vomiting, or diarrheacommon side effects of GLP-1 medications

However, the physiological substrates of OCTN1 are still matter of discussion (Pochini et al., 2019 and Table 1)

This marks the first time a GLP-1 drug gained a formal heart-health indication, underscoring that GLP-1 therapies now address both metabolic and cardiovascular disease